scholarly article | Q13442814 |
P356 | DOI | 10.1002/PSP4.12230 |
P8608 | Fatcat ID | release_akmz46jwmfaoho2qmvhkjtoiyy |
P953 | full work available at URL | http://eprints.whiterose.ac.uk/120105/ |
P932 | PMC publication ID | 5702902 |
P698 | PubMed publication ID | 28782239 |
P1154 | Scopus EID | 2-s2.0-85029030711 |
P50 | author | Nick Plant | Q42717895 |
J Bernadette Moore | Q47158643 | ||
Elaina M Maldonado | Q61831741 | ||
P2093 | author name string | Andrzej M Kierzek | |
Ciarán P Fisher | |||
Vytautas Leoncikas | |||
P2860 | cites work | Androgen receptor auto-regulates its expression by a negative feedback loop through upregulation of IFI16 protein | Q24305403 |
The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity | Q27632611 | ||
Theory for the systemic definition of metabolic pathways and their use in interpreting metabolic function from a pathway-oriented perspective | Q41724911 | ||
Basic Concepts in Physiologically Based Pharmacokinetic Modeling in Drug Discovery and Development | Q41768726 | ||
GSMN-TB: a web-based genome-scale network model of Mycobacterium tuberculosis metabolism | Q42130341 | ||
A tutorial on analysis and simulation of boolean gene regulatory network models | Q42934459 | ||
Integrating metabolic, transcriptional regulatory and signal transduction models in Escherichia coli. | Q43575020 | ||
Glucocorticoid-mediated induction of CYP3A4 is decreased by disruption of a protein: DNA interaction distinct from the pregnane X receptor response element | Q44094369 | ||
A multiscale, model-based analysis of the multi-tissue interplay underlying blood glucose regulation in type I diabetes. | Q47945637 | ||
Qualitatively modelling and analysing genetic regulatory networks: a Petri net approach | Q48423292 | ||
Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation | Q48433814 | ||
Petri nets: Properties, analysis and applications | Q54087085 | ||
ORGANIZATION FOR PHYSIOLOGICAL HOMEOSTASIS | Q56047924 | ||
Decreased ligand affinity rather than glucocorticoid receptor down-regulation in patients with endogenous Cushing's syndrome | Q73765414 | ||
Hybrid Petri net representation of gene regulatory network | Q74022089 | ||
Dexamethasone induces pregnane X receptor and retinoid X receptor-alpha expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators | Q74045627 | ||
Using Boolean Logic Modeling of Gene Regulatory Networks to Exploit the Links Between Cancer and Metabolism for Therapeutic Purposes | Q85946393 | ||
Homeostasis, inflammation, and disease susceptibility | Q28082739 | ||
A general definition of metabolic pathways useful for systematic organization and analysis of complex metabolic networks | Q28145745 | ||
What is flux balance analysis? | Q28275348 | ||
Optimization of stress response through the nuclear receptor-mediated cortisol signalling network | Q28397689 | ||
A PXR-Mediated Negative Feedback Loop Attenuates the Expression of CYP3A in Response to the PXR Agonist Pregnenalone-16α-Carbonitrile | Q28477056 | ||
Integrating cellular metabolism into a multiscale whole-body model | Q28484829 | ||
Fat synthesis in adipose tissue. An examination of stoichiometric constraints | Q30051073 | ||
Dynamic analysis of integrated signaling, metabolic, and regulatory networks | Q30441717 | ||
Predicting in vivo drug interactions from in vitro drug discovery data | Q31011412 | ||
Quantitative modeling of stochastic systems in molecular biology by using stochastic Petri nets | Q32061669 | ||
A Boolean model of the gene regulatory network underlying Mammalian cortical area development | Q33700672 | ||
Gene expression profiling, genetic networks, and cellular states: an integrating concept for tumorigenesis and drug discovery | Q33727371 | ||
Model-based dietary optimization for late-stage, levodopa-treated, Parkinson's disease patients | Q33917819 | ||
An enhanced Petri-net model to predict synergistic effects of pairwise drug combinations from gene microarray data | Q33936078 | ||
Regulation of Gene Expression in Flux Balance Models of Metabolism | Q34101809 | ||
HepatoNet1: a comprehensive metabolic reconstruction of the human hepatocyte for the analysis of liver physiology | Q34240836 | ||
Constraining the metabolic genotype-phenotype relationship using a phylogeny of in silico methods | Q34257056 | ||
Genomics, complexity and drug discovery: insights from Boolean network models of cellular regulation | Q34355237 | ||
Systems biology approaches for studying the pathogenesis of non-alcoholic fatty liver disease | Q34467142 | ||
A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer | Q35248192 | ||
Transcriptional regulation of the human pregnane-X receptor | Q36473472 | ||
Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation | Q36477750 | ||
Predicting drug-drug interactions: an FDA perspective | Q37214533 | ||
Use of randomized sampling for analysis of metabolic networks | Q37305068 | ||
Nuclear receptors: the controlling force in drug metabolism of the liver? | Q37557625 | ||
Mathematical modeling of gene expression: a guide for the perplexed biologist | Q37854593 | ||
Constraint-based models predict metabolic and associated cellular functions. | Q38178893 | ||
MUFINS: multi-formalism interaction network simulator. | Q38671211 | ||
JAK/STAT signalling--an executable model assembled from molecule-centred modules demonstrating a module-oriented database concept for systems and synthetic biology. | Q39188236 | ||
Optimal control of gene regulatory networks with effectiveness of multiple drugs: a Boolean network approach | Q39346133 | ||
Bayesian flux balance analysis applied to a skeletal muscle metabolic model. | Q39776363 | ||
Stoichiometric flux balance models quantitatively predict growth and metabolic by-product secretion in wild-type Escherichia coli W3110. | Q39916365 | ||
Homologous down regulation of the glucocorticoid receptor: the molecular machinery. | Q40822186 | ||
P433 | issue | 11 | |
P921 | main subject | pharmacokinetics | Q323936 |
metabolic network | Q2263094 | ||
P304 | page(s) | 732-746 | |
P577 | publication date | 2017-08-07 | |
P1433 | published in | CPT: pharmacometrics & systems pharmacology | Q27724610 |
P1476 | title | Integration of Genome Scale Metabolic Networks and Gene Regulation of Metabolic Enzymes With Physiologically Based Pharmacokinetics | |
P478 | volume | 6 |
Q58573333 | Development of an Infrastructure for the Prediction of Biological Endpoints in Industrial Environments. Lessons Learned at the eTOX Project |
Q58417407 | Multi-scale, whole-system models of liver metabolic adaptation to fat and sugar in non-alcoholic fatty liver disease |
Q53698735 | No effects without causes: the Iron Dysregulation and Dormant Microbes hypothesis for chronic, inflammatory diseases |
Q52586831 | Probabilistic risk assessment of gold nanoparticles after intravenous administration by integrating in vitro and in vivo toxicity with physiologically based pharmacokinetic modeling. |
Search more.